In Brief: MiniMed
This article was originally published in The Gray Sheet
Executive Summary
MiniMed: Names Terrance Gregg president and chief operating officer, filling a position left vacant by Peter Rule in October 1995. Gregg joined MiniMed in September 1994 as the firm's VP-regulatory affairs and clinical research. Before joining MiniMed, he served as VP-governmental affairs for Smith & Nephew's Ioptex Research division...
You may also be interested in...
Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress
Among four FDA regulatory items withdrawn from OMB review is “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” which the agency submitted in July 2020.
FDA To Ramp Up ASCA Pilot In 2021
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
Scotland's MGB Plots Phase III For Promising Antibacterial
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: